These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 20124329)
1. Role of OXA-23 and AdeABC efflux pump for acquiring carbapenem resistance in an Acinetobacter baumannii strain carrying the blaOXA-66 gene. Lee Y; Yum JH; Kim CK; Yong D; Jeon EH; Jeong SH; Ahn JY; Lee K Ann Clin Lab Sci; 2010; 40(1):43-8. PubMed ID: 20124329 [TBL] [Abstract][Full Text] [Related]
2. Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital. Huang L; Sun L; Xu G; Xia T Diagn Microbiol Infect Dis; 2008 Nov; 62(3):326-32. PubMed ID: 18687557 [TBL] [Abstract][Full Text] [Related]
3. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. Héritier C; Dubouix A; Poirel L; Marty N; Nordmann P J Antimicrob Chemother; 2005 Jan; 55(1):115-8. PubMed ID: 15590718 [TBL] [Abstract][Full Text] [Related]
4. Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene status. Esterly JS; Qi C; Malczynski M; Scheetz MH Pharmacotherapy; 2010 Apr; 30(4):354-60. PubMed ID: 20334455 [TBL] [Abstract][Full Text] [Related]
5. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708 [TBL] [Abstract][Full Text] [Related]
6. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857 [TBL] [Abstract][Full Text] [Related]
7. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii. Amudhan SM; Sekar U; Arunagiri K; Sekar B Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108 [TBL] [Abstract][Full Text] [Related]
8. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Ruiz M; Marti S; Fernandez-Cuenca F; Pascual A; Vila J Clin Microbiol Infect; 2007 Dec; 13(12):1192-8. PubMed ID: 17850347 [TBL] [Abstract][Full Text] [Related]
9. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan. Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015 [TBL] [Abstract][Full Text] [Related]
10. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil. Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152 [TBL] [Abstract][Full Text] [Related]
11. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. Koh TH; Sng LH; Wang GC; Hsu LY; Zhao Y J Antimicrob Chemother; 2007 Apr; 59(4):627-32. PubMed ID: 17284537 [TBL] [Abstract][Full Text] [Related]
12. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility. Zander E; Chmielarczyk A; Heczko P; Seifert H; Higgins PG J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718 [TBL] [Abstract][Full Text] [Related]
13. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007. McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083 [TBL] [Abstract][Full Text] [Related]
14. Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan. Lin YC; Sheng WH; Chen YC; Chang SC; Hsia KC; Li SY Int J Antimicrob Agents; 2010 May; 35(5):439-43. PubMed ID: 20106635 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii. Fernández Cuenca F; Sánchez Mdel C; Caballero-Moyano FJ; Vila J; Martínez-Martínez L; Bou G; Baño JR; Pascual A Int J Antimicrob Agents; 2012 Jun; 39(6):472-7. PubMed ID: 22445494 [TBL] [Abstract][Full Text] [Related]
16. [Mechanism of carbapenems resistance in Acinetobacter baumannii]. Wang H; Liu YM; Chen MJ; Sun HL; Xie XL; Xu YC Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):567-72. PubMed ID: 14650160 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Park YK; Jung SI; Park KH; Kim SH; Ko KS Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968 [TBL] [Abstract][Full Text] [Related]
19. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China. Hu Q; Hu Z; Li J; Tian B; Xu H; Li J J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808 [TBL] [Abstract][Full Text] [Related]